Susquehanna International Group, LLP Champions Oncology, Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$5.4 - $8.99 $132,354 - $220,344	-24,510 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$7.51 - $10.12 $225 - $303	30 Added 0.12%	24,510 $192,000
Q2 2019 Aug 14, 2019	BUY	$7.51 - $10.12 $61,949 - $83,479	8,249 Added 50.82%	24,480 $192,000
Q1 2019 May 15, 2019	BUY	$7.89 - $12.23 $128,062 - $198,505	16,231 New	16,231 $159,000
Q4 2018 Feb 14, 2019	SELL	$7.29 - $15.27 $74,460 - $155,967	-10,214 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.82 - $17.47 $59,445 - $178,438	10,214 New	10,214 $178,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.